Search

everythinglearnresearchcommunity

for

Search:↓

Chitosan hydrogels are promising for repairing blood vessels but need improvements in strength and compatibility.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

New genetic variants linked to albinism were found in Pakistani families.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Skin acetyl-CoA synthesis is crucial for overall lipid balance.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Berberine delivery systems improve wound healing by enhancing bioavailability, reducing inflammation, and promoting tissue regeneration.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Skin diseases are common in Greece and significantly affect people's lives and well-being.

Inclusive dermatology aims to provide personalized skin care for all by addressing diverse needs and disparities.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Patients with alopecia areata prefer effective, safe, and convenient treatments, especially topical ones.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Women with both type 2 diabetes and PCOS have worse metabolic issues but milder reproductive symptoms after sleeve gastrectomy.

Corneal cells can potentially revert to stem cells, aiding in repair and regeneration.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.